XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Total Rithm Capital Stockholders’ Equity
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Preferred stock, beginning balance (in shares) at Dec. 31, 2022     51,964,122,000          
Beginning balance at Dec. 31, 2022 $ 7,010,068 $ 6,943,001 $ 1,257,254 $ 4,739 $ 6,062,019 $ (418,662) $ 37,651 $ 67,067
Common stock, beginning balance (in shares) at Dec. 31, 2022       473,715,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Dividends declared on common stock (241,584) (241,584)       (241,584)    
Dividends declared on preferred stock (44,790) (44,790)       (44,790)   0
Capital distributions (12,405)             (12,405)
Cashless exercise of 2020 Warrants (in shares)       9,287,347,000        
Cashless exercise of 2020 Warrants 0 0   $ 93 (93)      
Director share grants and employee non-cash stock-based compensation (in shares)       318,159,000        
Director share grants and non-cash stock-based compensation 4,458 4,458   $ 2 6,687 (2,231)    
Comprehensive income (loss):                
Net income (loss) 476,634 471,045       471,045   5,589
Unrealized gain (loss) on available-for-sale securities, net 2,303 2,303         2,303  
Cumulative translation adjustment, net 0              
Deferred taxes 0              
Comprehensive income (loss) 478,937 473,348           5,589
Preferred stock, ending balance (in shares) at Jun. 30, 2023     51,964,122,000          
Ending balance at Jun. 30, 2023 7,194,684 7,134,433 $ 1,257,254 $ 4,834 6,068,613 (236,222) 39,954 60,251
Common stock, ending balance (in shares) at Jun. 30, 2023       483,320,606,000        
Preferred stock, beginning balance (in shares) at Mar. 31, 2023     51,964,122,000          
Beginning balance at Mar. 31, 2023 6,954,543 6,894,206 $ 1,257,254 $ 4,832 6,062,051 (470,562) 40,631 60,337
Common stock, beginning balance (in shares) at Mar. 31, 2023       483,017,747,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Dividends declared on common stock (120,830) (120,830)       (120,830)    
Dividends declared on preferred stock (22,395) (22,395)       (22,395)    
Capital distributions (6,975)             (6,975)
Director share grants and employee non-cash stock-based compensation (in shares)       302,859,000        
Director share grants and non-cash stock-based compensation 4,333 4,333   $ 2 6,562 (2,231)    
Comprehensive income (loss):                
Net income (loss) 386,685 379,796       379,796   6,889
Unrealized gain (loss) on available-for-sale securities, net (677) (677)         (677)  
Cumulative translation adjustment, net 0              
Deferred taxes 0              
Comprehensive income (loss) 386,008 379,119           6,889
Preferred stock, ending balance (in shares) at Jun. 30, 2023     51,964,122,000          
Ending balance at Jun. 30, 2023 $ 7,194,684 7,134,433 $ 1,257,254 $ 4,834 6,068,613 (236,222) 39,954 60,251
Common stock, ending balance (in shares) at Jun. 30, 2023       483,320,606,000        
Preferred stock, beginning balance (in shares) at Dec. 31, 2023 51,964,122   51,964,122,000          
Beginning balance at Dec. 31, 2023 $ 7,101,038 7,006,942 $ 1,257,254 $ 4,833 6,074,322 (373,141) 43,674 94,096
Common stock, beginning balance (in shares) at Dec. 31, 2023 483,226,239     483,226,239,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Dividends declared on common stock $ (243,302) (243,302)       (243,302)    
Dividends declared on preferred stock (44,790) (44,790)       (44,790)   0
Capital contributions 32,435             32,435
Capital distributions (12,881)             (12,881)
Issuance of common stock (in shares)       6,097,793,000        
Issuance of common stock 69,250 69,250   $ 60 69,190      
Purchase of non-controlling interest (26,042) 0           (26,042)
Director share grants and employee non-cash stock-based compensation (in shares)       408,390,000        
Director share grants and non-cash stock-based compensation 17,821 17,821   $ 4 19,360 (1,543)    
Comprehensive income (loss):                
Net income (loss) 526,004 519,591       519,591   6,413
Unrealized gain (loss) on available-for-sale securities, net 2,015 2,015         2,015  
Cumulative translation adjustment, net (1,074) (1,074)         (1,074)  
Deferred taxes 140 140         140  
Comprehensive income (loss) $ 527,085 520,672           6,413
Preferred stock, ending balance (in shares) at Jun. 30, 2024 51,964,122   51,964,122,000          
Ending balance at Jun. 30, 2024 $ 7,420,614 7,326,593 $ 1,257,254 $ 4,897 6,162,872 (143,185) 44,755 94,021
Common stock, ending balance (in shares) at Jun. 30, 2024 489,732,422     489,732,422,000        
Preferred stock, beginning balance (in shares) at Mar. 31, 2024     51,964,122,000          
Beginning balance at Mar. 31, 2024 $ 7,243,372 7,149,552 $ 1,257,254 $ 4,836 6,075,080 (232,119) 44,501 93,820
Common stock, beginning balance (in shares) at Mar. 31, 2024       483,477,713,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Dividends declared on common stock (122,433) (122,433)       (122,433)    
Dividends declared on preferred stock (22,395) (22,395)       (22,395)    
Capital contributions 30,297             30,297
Capital distributions (7,015)             (7,015)
Issuance of common stock (in shares)       6,097,793,000        
Issuance of common stock 69,250 69,250   $ 60 69,190      
Purchase of non-controlling interest (26,042) 0           (26,042)
Director share grants and employee non-cash stock-based compensation (in shares)       156,916,000        
Director share grants and non-cash stock-based compensation 16,809 16,809   $ 1 18,602 (1,794)    
Comprehensive income (loss):                
Net income (loss) 238,517 235,556       235,556   2,961
Unrealized gain (loss) on available-for-sale securities, net 412 412         412  
Cumulative translation adjustment, net (204) (204)         (204)  
Deferred taxes 46 46         46  
Comprehensive income (loss) $ 238,771 235,810           2,961
Preferred stock, ending balance (in shares) at Jun. 30, 2024 51,964,122   51,964,122,000          
Ending balance at Jun. 30, 2024 $ 7,420,614 $ 7,326,593 $ 1,257,254 $ 4,897 $ 6,162,872 $ (143,185) $ 44,755 $ 94,021
Common stock, ending balance (in shares) at Jun. 30, 2024 489,732,422     489,732,422,000